Jones Financial Companies
CLLS

Jones Financial Companies’s Cellectis CLLS Stock Holding History

Jones Financial Companies’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$142 Buy
+50
New +$178 ﹤0.01% 4872

Other funds holding CLLS

BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jones Financial Companies's CLLS Position: Q2 2026 in Review

Jones Financial Companies opened a new position in Cellectis (CLLS) in Q2 2026: 50 shares worth $142. The stake represents ﹤0.01% of the portfolio and ranks #4872 among its holdings.

27 funds tracked by Wall St. Rank hold CLLS as of Q2 2026.

  • Jones Financial Companies held 50 shares of Cellectis worth $142 as of Q2 2026.
  • Cellectis was a new Jones Financial Companies position in Q2 2026.
  • Cellectis made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4872 holding.
  • 27 funds tracked by Wall St. Rank held Cellectis as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.